Two area biotechs raise $210M in IPOs, then watch shares soar

Cambridge-based Solid Biosciences and Boston-based resTORbio raised a combined $210 million in initial public offerings over the past day, and as of 3 p.m. Friday both the company ’s shares were trading significantly up from the IPO price. Solid Biosciences, a company working on drugs to treat Duchenne muscular dystrophy, raised $125 million by pricing its shares at $16, below the $18 to $19 range first proposed. The reason appears to be a disclosure Thursday morning in a federal filing that the…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news